Dec 8, 2020 CloudMD Software & Services Inc.

CloudMD to Present at Benzinga Global Small Cap Conference and LD Micro in December

VANCOUVER, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV:DOC)(OTCQB:DOCRF)(Frankfurt: 6PH) (the “Company” or “CloudMD”), a telemedicine company seeking to revolutionize the delivery of healthcare to patients, is pleased to announce that CEO, Dr. Essam Hamza will be presenting at the following upcoming virtual investor conferences:

Benzinga Global Small Cap Conference, Today, December 8, 2020

  • Dr. Essam Hamza will be presenting CloudMD at 10:15am EST (7:15am PST) on Track 2

The Benzinga Global Small Cap Conference bridges the gap between Small Cap companies, investors, and traders. Learn about small-cap investing with clearly defined educational modules, take a look at a curated group of small-cap investment opportunities, and connect with the global small-cap audience in an intimate, virtual setting. To register for this virtual conference, visit: https://bit.ly/39KCd2G

LD Micro, December 14 – 15, 2020

  • Dr. Essam Hamza will be presenting CloudMD at 10am EST (7am PST) on December 14th on Track 2

LD Micro is the host of the most influential conferences in the small-cap world. With the recent SRAX acquisition, LD has access to the largest active base of micro-cap investors in the world at over 2 million and counting. To register for this virtual conference, visit https://ve.mysequire.com

About CloudMD Software & Services

CloudMD Software & Services Inc. (TSXV:DOC)(OTCQB:DOCRF)(Frankfurt: 6PH) is digitizing the delivery of healthcare by providing a patient-centric approach, with an emphasis on continuity of care. The Company offers SAAS-based health technology solutions to healthcare providers across North America and has developed proprietary technology that delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, educational resources, and artificial intelligence (AI). CloudMD currently services a combined ecosystem of over 500 clinics, almost 4000 licensed practitioners, and 8 million patient charts across North America.

Forward-Looking Statements

This news release contains forward-looking statements that are based on CloudMD’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business. Although CloudMD believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and CloudMD undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Please See Disclaimer

 

STOCKS YOU MAY LIKE


Disclosure:

1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.

2) The Article was issued on behalf of and sponsored by CloudMD Software & Services Inc. Market Jar Media Inc. expects to receive from CloudMD Software & Services Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) one hundred eighty nine thousand CAD Dollars for 32 campaign days (23 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.